<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="30588" whole_study_id="26149" phs="001493" v="2" p="1" createDate="2018-07-16T12:25:00-05:00" completedByGPADate="2018-08-06T14:18:52-05:00" modDate="2020-08-26T22:13:22-05:00" maxParentChildStudyModDate="2020-08-26T22:13:22-05:00" handle="RCC_ImmuneCheckpoint" num_participants="72"><StudyInfo accession="phs001493.v2.p1" parentAccession="phs001493.v2.p1"><BioProject id="PRJNA420785" entrez_id="420785" type="bp_admin_access"/><BioProject id="PRJNA420786" entrez_id="420786" type="bp_data_submission"/><StudyNameEntrez>Whole Exome Predictors of Immune Checkpoint Therapy Response in Renal Cell Carcinoma</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/><StudyType22 name="whole_targ_exome"/><StudyType22 name="rnaseq_whole_targ_transcriptome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="tumor_normal"/><StudyType22 name="dna"/><StudyType22 name="rna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>individual_sequencing</StudyType><StudyType>tumor_normal</StudyType><StudyType>dna</StudyType><StudyType>rna</StudyType><StudyType>whole_exome</StudyType><StudyType>whole_transcriptome</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person aid="8" auth="virtual" fname="Eliezer" lname="Van Allen" email="eliezer@broadinstitute.org"><Role>PI</Role><Organization/></Person><Person aid="8" auth="virtual" fname="Adam" lname="Tracy" email="atracy@broadinstitute.org"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014392987" aid="1" auth="cit" login="fingerma" fname="Ian" mname="Michael" lname="Fingerman" email="fingerma@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>This study was supported by an AACR KureIt grant. 

</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_by_timeout" gsr_mode_label="Unrestricted access (institution did not respond within six months)"/><ConsentGroup uid="2674" CGType="cg_class_GRU" title="General Research Use" name="GRU" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data is limited only by the terms of the model Data Use Certification.

</Use-Restriction></ConsentGroup><ConsentGroup uid="2835" CGType="cg_class_DS" title="Disease-Specific (Cancer, MDS)" name="DS-CA-MDS" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Cancer.
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="26149" whole_study_id="26149" phs="001493" v="1" p="1" createDate="2017-07-21T14:01:44-05:00" completedByGPADate="2017-07-21T14:39:08-05:00" modDate="2020-09-01T11:19:11-05:00" maxParentChildStudyModDate="2020-09-01T11:19:11-05:00" handle="RCC_ImmuneCheckpoint" num_participants="72"><StudyInfo accession="phs001493.v1.p1" parentAccession="phs001493.v1.p1"><BioProject id="PRJNA420785" entrez_id="420785" type="bp_admin_access"/><BioProject id="PRJNA420786" entrez_id="420786" type="bp_data_submission"/><StudyNameEntrez>Whole Exome Predictors of Immune Checkpoint Therapy Response in Renal Cell Carcinoma</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/><StudyType22 name="whole_targ_exome"/><StudyType22 name="rnaseq_whole_targ_transcriptome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="tumor_normal"/><StudyType22 name="dna"/><StudyType22 name="rna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>individual_sequencing</StudyType><StudyType>tumor_normal</StudyType><StudyType>dna</StudyType><StudyType>rna</StudyType><StudyType>whole_exome</StudyType><StudyType>whole_transcriptome</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="false" is_admin_ic="true" primary="true"/></ICs><Persons><Person aid="8" auth="virtual" fname="Eliezer" lname="Van Allen" email="eliezer@broadinstitute.org"><Role>PI</Role><Organization/></Person><Person aid="8" auth="virtual" fname="Adam" lname="Tracy" email="atracy@broadinstitute.org"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014392987" aid="1" auth="cit" login="fingerma" fname="Ian" mname="Michael" lname="Fingerman" email="fingerma@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>This study was supported by an AACR KureIt grant. 

</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><ConsentGroup uid="2674" CGType="cg_class_GRU" title="General Research Use" name="GRU" dac_uid="62" dac_name="eNCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data is limited only by the terms of the model Data Use Certification.

</Use-Restriction></ConsentGroup><ConsentGroup uid="2835" CGType="cg_class_DS" title="Disease-Specific (Cancer, MDS)" name="DS-CA-MDS" dac_uid="62" dac_name="eNCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Cancer.
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>